论文部分内容阅读
目的探讨654-2注射液调和云南白药敷脐治疗小儿功能性再发性腹痛的临床疗效。方法将60例功能性再发性腹痛患儿随机分为对照组和治疗组,对照组30例口服颠茄合剂,3次/d,连服3 d,同时口服双歧杆菌四联活菌片(思连康),2~3岁0.5 g/次,4~6岁1.0 g/次,7~9岁1.5 g/次,3次/d,连服1周。治疗组30例以654-2注射液调和云南白药敷脐,2次/d,4 d为1个疗程,隔3 d进行下1个疗程,2个疗程后观察疗效。结果 2组腹痛症状均有所改善,治疗组总有效率为90.0%,对照组为70.0%,2组比较差异有统计意义(P<0.05)。结论采用654-2注射液调和云南白药敷脐疗法治疗小儿功能性再发性腹痛疗效显著,值得临床推广应用。
Objective To investigate the clinical efficacy of 654-2 injection in reconciling Yunna Baiyao Umbilicus to treat functional recurrent abdominal pain in children. Methods Sixty children with functional recurrent abdominal pain were randomly divided into control group and treatment group. In the control group, 30 patients were treated with oral administration of Belladonna mixture three times a day for 3 days, and oral live Bifidobacterium quadriceps (Silian Kang), 2 to 3 years old 0.5 g / time, 4 to 6 years old 1.0 g / time, 7 to 9 years old 1.5 g / time, 3 times / d, and even served for 1 week. Treatment group, 30 cases of 654-2 injection of Yunnanbaiyao Umbilical application, 2 times / d, 4 d for a course of treatment, every 3 d for a course of treatment, 2 after treatment to observe the effect. Results The symptoms of abdominal pain were improved in both groups. The total effective rate was 90.0% in the treatment group and 70.0% in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion 654-2 injection reconcile Yunnanbaiyin umbilical therapy in children with functional recurrent abdominal pain has remarkable curative effect and is worthy of clinical application.